Amoxicillin Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2028 - EIN News
Reports And Data
Advancements in combination drug development and improved regulations for amoxicillin
NEW YORK, NY, UNITED STATES, December 15, 2021 /EINPresswire.com/ -- According to the current analysis of Reports and Data, the global Amoxicillin market was valued at USD 4,570.5 Million in 2020 and is expected to reach USD 5,072.9 Million by the year 2028, at a CAGR of 1.30%. The amoxicillin antibiotics is a generic category of drug. It is also known by the name Amoxil and is usually administered in the treatment involving bacterial infections. The compound belongs to the β-lactam drug class of antibiotics. The amoxicillin medication is used in treating infections such as, pneumonia, ear infections, bronchitis, sinusitis, infections of the skin, and urinary tract infection (UTI). Its use for UTI is found to be used most than any other antibiotics. This antibiotic can also be taken in combinations with other drugs, such as amoxicillin and clavulanate potassium, it is used for treating bacterial infections mentioned before. The use of amoxicillin antibiotics for tooth infection is also popular. The increasing frequencies of bacterial infections in low-income countries, developing countries and other parts of the world will be the most significant factor in driving the growth of this market. Also the increasing research and applications of combination drugs with this medication will fasten the progress of the market. Furthermore, these medicines are safe to be taken together with birth control pills. Although, the possible side effects of amoxicillin are expected to hamper the development of the market to some extent.
The market is segmented on the basis of the diseases, the route administration, drug formulation, and distribution channels involved in distributing the medicine. The medication is available in tablet, capsule, suspension, syrup, and powder form, through hospital pharmacies, drug stores, retail stores and online pharmacies. It can be taken orally and through intravenous route as well. Some specific combinational medications are also prescribed for pregnant women. It includes, erythromycin or clarithromycin in combination with amoxicillin if the patient is pregnant with moderately severe infection; and Co-amoxiclav with clarithromycin, or erythromycin if the patient is pregnant with high-severity infection.
On the basis of geography, the North America segment is observed to be the fastest growing market, owing it to the growing number of clinical trials, research and development scenarios in the region. Europe is expected to perform good with Asia Pacific expected to growth with the highest CAGR across the world. Europe segment growth is anticipated to get impeded to some extends due to the announcement by government about its decision to reduce antibiotic prescriptions by around 15% this year, as part of a new plan to control antimicrobial resistance by 2040.
Furthermore, increased government initiatives for encouraging the use of this medicine, availability of research funds from private as well as public bodies, improvement in the reimbursement scenario, and rising awareness about multiple benefits of amoxicillin prescription are among the key factors propelling the growth of the market. Other medication alternatives of antibiotic amoxicillin are anticipated to impede the market growth. However according to a recent update from Journal of the American College of Cardiology it was found that Cipro or Ciprofloxacin, owns huge risk of escalating a heart-valve problem than another broad-spectrum antibiotic specifically amoxicillin.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2151
The report is formulated through exhaustive primary and secondary research which is verified and validated by industry experts, research analysts, and professionals. The report aims to help readers and users improve their business performances by providing insightful data about business sphere such as recent technological development, product advancements, and adoption of strategic business steps. The report also offers extensive analysis of the competitive landscape along with business overviews, expansion plans, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product and brand promotions, government and corporate deals, and partnerships among others.
Top Companies in the Market Include:
JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP., Sanis Health Inc, Nucare Pharmaceuticals, Inc., Northwind Pharmaceuticals, A-S Medication Solutions, Bryant ranch prepack and others., collectively constituting a competitive market
Increasing focus on development of vaccines to combat COVID-19 pandemic and focus on preventive medicine to mitigate future epidemics and pandemics, rising number of product approvals for drugs and therapeutics, and rapid digital transformation in the pharmaceutical and healthcare industry are some key factors expected to drive revenue growth over the forecast period. With the social distancing norms in place and growing focus on telemedicine, digital technologies were adopted at an accelerated rate allowing healthcare professionals to efficiently manage health of the patients. One of the most crucial drivers of the pharma & healthcare industry is the rapid integration of artificial intelligence in key areas such as R&D, patient care, commercialization, and drug discovery and development. It has also led to a reduction in healthcare expenditure and improved efficiency of the systems which is expected to further contribute to revenue growth of the market going ahead.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2151
Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter's Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered. The report is segmented on the basis of product types offered in the market, application spectrum, and key regions of the Amoxicillin market.
Further key findings from the report suggest
• The online pharmacies segment is expected to grow with a CAGR of 1.9% during the forecast period. Retail pharmacies i.e. drug stores remains the chief revenue generating segment in global market for the target antibiotic drug.
• Antibiotics are used to save thousands of lives each year by killing the harmful bacteria in the body. However these antibiotics destroys the desired bacteria in the human intestines, known as the microbiome, as well, which can result into potential health problems. Doctors are aware now that each antibiotic prescription has the potential to lead to some very harmful microbiome-related health outcomes in the patient. These dynamics hold the potential to disrupt the market of amoxicillin.
• A study on effectiveness of antibiotics on treating non severe acute exacerbations in children with non-cystic fibrosis bronchiectasis recently claimed that amoxicillin should remain the first line antibiotic for treating the same. The study took three antibiotics under consideration in the study, placebo, azithromycin plus placebo amoxicillin clavunate.
• There is an assortment of branded and generic rendition of amoxicillin medications are accessible in the market. Many manufacturers are manufacturing amoxicillin sedates and conveying in the market. The amoxicillin medications can likewise utilize a blend with different medications used to treat a bacterial disease, for example, triple treatment (amoxicillin/clarithromycin/lansoprazole) and double treatment (amoxicillin/lansoprazole). These double and triple treatments are under clinical preliminaries.
• North America remains the key revenue generating geographical segment in Amoxicillin market. The geographical segment accounted for USD 1.42 billion in 2018. Availability of research funds from public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements scenarios, rising focus on precision medicine, and rising awareness about treatments of infectious diseases, are among the key factors driving the market growth for Amoxicillin in this region.
To know more about the report @ https://www.reportsanddata.com/report-detail/amoxicillin-market
For the purpose of this report, Reports and Data has segmented the Amoxicillin market on the basis of infection type, form of drug, route, distribution channel and region:
Infection Type Outlook (Revenue in Million USD; 2018–2028)
• Skin Infections
• ENT (Ear, Nose & Throat) Infections
• Stomach Infections
• Lungs Infections
• Urinary tract infections (UTI)
• Pneumonia
• Bronchitis
• Gonorrhea
Route of Administration Outlook (Revenue in Million USD; 2018–2028)
• Oral
• Intravenous
Form Outlook (Revenue in Million USD; 2018–2028)
• Tablets
• Capsule
• Suspensions
• Syrup
• Powder
Distribution Channels Outlook (Revenue in Million USD; 2018–2028)
• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Key Regions Studied in the Report:
• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, France, Rest of Europe)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2151
Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.
Browse More Reports:
Parenteral Nutrition Market @ https://www.globenewswire.com/news-release/2019/10/15/1929504/0/en/Parenteral-Nutrition-Market-To-Reach-USD-8-29-Billion-By-2026-Reports-And-Data.html
Medical Scheduling Software Market @ https://www.globenewswire.com/news-release/2019/10/28/1936515/0/en/Medical-Scheduling-Software-Market-To-Reach-USD-612-5-Million-By-2026-Reports-And-Data.html
Medical Laser Systems Market @ https://www.globenewswire.com/news-release/2020/10/08/2105379/0/en/Medical-Laser-Market-revenue-to-cross-USD-10-Bn-by-2026-Global-Market-Insights-Inc.html
Medical Device Outsourcing Market @ https://www.globenewswire.com/news-release/2019/11/20/1950358/0/en/Medical-Device-Outsourcing-Market-To-Reach-USD-208-36-Billion-By-2026-Reports-And-Data.html
Personal Mobility Device Market @ https://www.globenewswire.com/news-release/2019/12/13/1960230/0/en/Personal-Mobility-Devices-Market-To-Reach-USD-12426-0-Million-By-2026-Reports-And-Data.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Comments
Post a Comment